Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients

Background. Nonalcoholic fatty liver disease (NAFLD) is a rising indication for liver transplantation (LT). Identification of NAFLD recurrence and those at risk for more progressive disease after LT remains elusive as the diagnosis requires biopsy, which is invasive and impractical for serial monito...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher J. Mowry, MD, Cristina Alonso, PhD, Marta Iruarrizaga-Lejarreta, PhD, Pablo Ortiz, MD, PhD, Josh Levitsky, MD, MS, Mary Rinella, MD
Format: article
Language:EN
Published: Wolters Kluwer 2021
Subjects:
Online Access:https://doaj.org/article/7d381d77ca3448e398a9f05fef8fee10
Tags: Add Tag
No Tags, Be the first to tag this record!